Jakob Emerson on Payer Trends, AI ROI and UnitedHealth's Expanding Financial Business
Becker’s Healthcare PodcastSummary
UnitedHealth recently acquired Allegius, a benefits administration platform, for $3 billion, signaling a strategic move to enhance its financial services sector. This acquisition aligns with UnitedHealth's goal to expand margins in a low-margin insurance environment, particularly as it faces challenges in Medicare Advantage markets. Allegius manages 26 million members and processes $6 billion in healthcare payments annually, including health savings accounts and COBRA coverage. The purchase reflects UnitedHealth's focus on growing revenue through financial services, which has become a priority for the company.
In a contrasting perspective, Centene's CEO emphasized the need for tangible returns on AI investments during a recent earnings call. Unlike many insurers that highlight broad AI initiatives, Centene is cautious about deploying AI solely for investor appeal. Instead, the company focuses on practical applications, such as financial forecasting and fraud detection, to ensure that AI contributes to measurable improvements. This approach underscores a growing trend among insurers to prioritize effective use of technology over mere investment rhetoric, particularly in a challenging financial landscape.
Show Notes
In this episode, Jakob Emerson, Associate News Director, Becker’s Healthcare, discusses UnitedHealth's $3 billion acquisition of Allegis, the evolving Medicare Advantage and Medicaid landscape, and how insurers are approaching AI investments. He also explores the growing focus on measurable AI returns, proprietary data and the challenges of using AI in healthcare.
More from Becker’s Healthcare Podcast
This episode recorded live at the Becker's 11th Annual Health IT + Digital Health + RCM Conference features Tinu Tadese, MD, System Chief Medical Informatics Officer, Boston Medical Center, who discusses reducing data fragmentation, preserving clinical context across care transitions and turning patient data into actionable insights
In this episode, John D’Angelo, MD, President and CEO of Northwell Health, discusses a fundamentally different approach to treating rheumatoid arthritis (RA): bioelectronic medicine, which uses the body’s own nervous system to help regulate the inflammation that drives the disease. Delivered by a small implanted medical device that stimulates the vagus nerve, the FDA-approved therapy offers an alternative to costly medications that can also cause significant side effects or fail to provide adequate relief.
In this episode, Ryan Mezinger, Senior Vice President and Chief Pharmacy Officer at MetroHealth, and Dr. Amit Gir, CEO and Co-Founder of Phox Health, discuss how MetroHealth's pharmacy delivery model is improving medication access, adherence, patient satisfaction, and care continuity while strengthening chain of custody and pharmacy operations.
In this episode, Dr. Kyle W. Trecartin, Chief Medical Officer, Beth Israel Deaconess Hospital - Plymouth, discusses improving patient throughput, strengthening quality and safety through a just culture, and expanding access to care in the community.
In this episode, Erica Rowe Urquhart, MD, PhD, Orthopedic Surgeon, Author, Healthcare Thought Leader, discusses how reimbursement pressures shape independent medical practices, why physicians must understand healthcare finance, and the leadership skills needed to sustain quality patient care.